These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6191342)

  • 1. Structure and biological function of La Crosse G1 glycoprotein.
    Kingsford L
    Prog Clin Biol Res; 1983; 123():157-66. PubMed ID: 6191342
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibodies against La Crosse virus.
    Grady LJ; Srihongse S; Grayson MA; Deibel R
    J Gen Virol; 1983 Aug; 64 (Pt 8)():1699-704. PubMed ID: 6192204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies against the G1 and nucleocapsid proteins of LaCrosse and Tahyna viruses.
    Gonzalez-Scarano F; Shope RE; Calisher CH; Nathanson N
    Prog Clin Biol Res; 1983; 123():145-56. PubMed ID: 6191341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activities of monoclonal antibodies reactive with antigenic sites mapped on the G1 glycoprotein of La Crosse virus.
    Kingsford L; Ishizawa LD; Hill DW
    Virology; 1983 Sep; 129(2):443-55. PubMed ID: 6194614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for three separate antigenic sites on the G1 protein of La Crosse Virus.
    Grady LJ; Sanders ML; Campbell WP
    Virology; 1983 Apr; 126(1):395-7. PubMed ID: 6189289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the oligosaccharides of Inkoo virus envelope glycoproteins.
    Pesonen M; Rönnholm R; Kuismanen E; Pettersson RF
    J Gen Virol; 1982 Dec; 63(2):425-34. PubMed ID: 7153764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitopes of the G1 glycoprotein of La Crosse virus form overlapping clusters within a single antigenic site.
    Najjar JA; Gentsch JR; Nathanson N; Gonzalez-Scarano F
    Virology; 1985 Jul; 144(2):426-32. PubMed ID: 2414920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two monoclonal antibodies against La Crosse virus show host-dependent neutralizing activity.
    Grady LJ; Kinch W
    J Gen Virol; 1985 Dec; 66 ( Pt 12)():2773-6. PubMed ID: 4067586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies specific for the G1 glycoprotein of La Crosse virus that react with other California serogroup viruses.
    Kingsford L; Boucquey KH
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():523-30. PubMed ID: 2179465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interactionof antiody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies.
    Lefrancios L; Lyles DS
    Virology; 1982 Aug; 121(1):157-67. PubMed ID: 6180550
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of proteolytic cleavage of La Crosse virus G1 glycoprotein on antibody neutralization.
    Kingsford L; Hill DW
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2147-56. PubMed ID: 6352863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jamestown Canyon virus: the etiologic agent of an emerging human disease?
    Deibel R; Srihongse S; Grayson MA; Grimstad PR; Mahdy MS; Artsob H; Calisher CH
    Prog Clin Biol Res; 1983; 123():313-25. PubMed ID: 6191343
    [No Abstract]   [Full Text] [Related]  

  • 13. Oligosaccharides of the California encephalitis viruses.
    Vorndam AV; Trent DW
    Virology; 1979 May; 95(1):1-7. PubMed ID: 442535
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid diagnosis of La Crosse virus infections: evaluation of serologic and antigen detection techniques for the clinically relevant diagnosis of La Crosse encephalitis.
    Beaty BJ; Jamnback TL; Hildreth SW; Brown KL
    Prog Clin Biol Res; 1983; 123():293-302. PubMed ID: 6346337
    [No Abstract]   [Full Text] [Related]  

  • 15. An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function.
    Gonzalez-Scarano F; Janssen RS; Najjar JA; Pobjecky N; Nathanson N
    J Virol; 1985 Jun; 54(3):757-63. PubMed ID: 3889368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of monoclonal antibodies against the G1 and N proteins of LaCrosse and Tahyna, two California serogroup bunyaviruses.
    Gonzalez-Scarano F; Shope RE; Calisher CE; Nathanson N
    Virology; 1982 Jul; 120(1):42-53. PubMed ID: 7101727
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudotype formation with La Crosse virus glycoproteins.
    Bupp K; González-Scarano F
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():667-71. PubMed ID: 9568959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural proteins of La Crosse virus.
    Obijeski JF; Bishop DH; Murphy FA; Palmer EL
    J Virol; 1976 Sep; 19(3):985-97. PubMed ID: 972436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies define eight independent antigenic regions on the bovine leukemia virus (BLV) envelope glycoprotein gp51.
    Bruck C; Mathot S; Portetelle D; Berte C; Franssen JD; Herion P; Burny A
    Virology; 1982 Oct; 122(2):342-52. PubMed ID: 6183819
    [No Abstract]   [Full Text] [Related]  

  • 20. Bunyavirus gene structure - function relationships and potential for RNA segment reassortment in the vector: La Crosse and snowshoe hare reassortant viruses in mosquitoes.
    Beaty BJ; Fuller F; Bishop DH
    Prog Clin Biol Res; 1983; 123():119-28. PubMed ID: 6867030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.